Answers are grounded in this paper and cite their sources.
Summary The somatic hypermutation (SHM) status of the immunoglobulin heavy variable (IGHV) gene is a key prognostic and predictive biomarker in chronic lymphocytic leukaemia (CLL). Current methods, including Sanger sequencing and short‐read next‐generation sequencing, are accurate but have limitations in scalability and turnaround time. Here, we present an integrated workflow for multiplexed long‐read nanopore sequencing of full‐length IGHV‐IGHD‐IGHJ rearrangements, leveraging recent advances in sequencing chemistry and base calling. Peripheral blood samples from 60 patients with CLL, representing diverse IGHV subgroups and SHM levels, were analysed. Single‐step polymerase chain reaction (PCR) amplification with EuroClonality‐based primers and simultaneous barcoding enabled multiplexing of 12 samples per run. Sequencing on the MinION platform generated over 200 000 high‐quality (≥Q30) reads per sample after quality filtering. A dominant productive clonotype was identified in all cases (mean abundance 75%). Comparative analysis demonstrated high concordance with Illumina‐based results for IGHV‐IGHD‐IGHJ gene usage and SHM status. Secondary rearrangements with a frequency of >5% were consistently detected across platforms. The workflow enabled a turnaround time below 24 h at an estimated cost of approximately €70 per sample. In summary, these findings establish long‐read sequencing as a rapid, accurate and cost‐effective method for full‐length IGHV gene SHM assessment, supporting its implementation in routine clinical diagnostics.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: